Network pharmacology and in silico toxicometabolomic profiling of larixinic acid from thermally processed camel milk: Implications for cancer and regenerative therapeutics

Camel milk has been used as a staple food in different parts of the world, due to its richness with several potential agents that enhance the health benefits in humans. Camel milk subjected to thermal processes enhances the accumulation of larixinic acid, a natural compound that enhances the flavor of the milk and is used as a flavoring agent in food. Based on the reports, larixinic acid (LAM1) was investigated in the present study for its therapeutic potential. MetaTox analysis revealed three metabolites: LAM2 and LAM4 (epoxidation products) and LAM3 (a glucuronidated product). The study highlighted their distinct pharmacological and toxicological profiles. LAM1 and its metabolites demonstrated a broad spectrum of biological activities such as apoptosis regulation, vascular activity, neuroprotection, and immune modulation. SwissTarget search retrieved 203 proteins that are classified as shared and unique proteins. The STRING network-based approach unravels the hub proteins involved in viral carcinogenesis, tyrosine-protein kinase activity, and anaplastic lymphoma kinase (ALK) signaling pathways. Among the metabolites, LAM3 interaction revealed 22 hub proteins involved mainly in smooth muscle cell proliferation. The LAM4 network revealed 13 hub proteins that are involved in nucleotide synthesis and metabolic pathways. Functional enrichment analysis using the DAVID tool revealed diverse biological, cellular, and molecular functions of the proteins. Through Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis the pathways were classified as central pathways (metabolic process, nucleotide, and nitrogen metabolism), specific pathways (TNF signaling, IL-17 signaling, and folate biosynthesis), and regulatory pathways (microRNAs in cancer and apoptosis-related pathway). The pathways emphasize the role of metabolites and their significance in tumorigenesis and therapeutic mechanisms. Among the metabolites, LAM3 shows a promising role in DNA repair, leucocyte adhesion, and smooth muscle proliferation. These significant roles make LAM3 a promising candidate for therapeutic applications involving cancer, regenerative medicine, and inflammatory disease. LAM4 specifically shows interaction with proteins that are involved in response to hypoxia and negative regulation of proliferation suggesting their potential role in cancer treatment. These network pharmacology-based investigations revealed larixinic acid and its metabolites as promising candidates for therapeutic development.

Authors

Institutions

Publication Details

Journal
Journal of King Saud University - Science
Published
2026-11-19
DOI
https://doi.org/10.25259/jksus_708_2026
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Network pharmacology and in silico toxicometabolomic profiling of larixinic acid from thermally processed camel milk: Implications for cancer and regenerative therapeutics

Abdulaziz S. Alothaim, Rajendran Vijayakumar
Journal of King Saud University - Science
Computational Drug Discovery Methods
article

Network pharmacology and in silico toxicometabolomic profiling of larixinic acid from thermally processed camel milk: Implications for cancer and regenerative therapeutics

Abdulaziz S. Alothaim, Rajendran Vijayakumar
article en

Abstract

Camel milk has been used as a staple food in different parts of the world, due to its richness with several potential agents that enhance the health benefits in humans. Camel milk subjected to thermal processes enhances the accumulation of larixinic acid, a natural compound that enhances the flavor of the milk and is used as a flavoring agent in food. Based on the reports, larixinic acid (LAM1) was investigated in the present study for its therapeutic potential. MetaTox analysis revealed three metabolites: LAM2 and LAM4 (epoxidation products) and LAM3 (a glucuronidated product). The study highlighted their distinct pharmacological and toxicological profiles. LAM1 and its metabolites demonstrated a broad spectrum of biological activities such as apoptosis regulation, vascular activity, neuroprotection, and immune modulation. SwissTarget search retrieved 203 proteins that are classified as shared and unique proteins. The STRING network-based approach unravels the hub proteins involved in viral carcinogenesis, tyrosine-protein kinase activity, and anaplastic lymphoma kinase (ALK) signaling pathways. Among the metabolites, LAM3 interaction revealed 22 hub proteins involved mainly in smooth muscle cell proliferation. The LAM4 network revealed 13 hub proteins that are involved in nucleotide synthesis and metabolic pathways. Functional enrichment analysis using the DAVID tool revealed diverse biological, cellular, and molecular functions of the proteins. Through Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis the pathways were classified as central pathways (metabolic process, nucleotide, and nitrogen metabolism), specific pathways (TNF signaling, IL-17 signaling, and folate biosynthesis), and regulatory pathways (microRNAs in cancer and apoptosis-related pathway). The pathways emphasize the role of metabolites and their significance in tumorigenesis and therapeutic mechanisms. Among the metabolites, LAM3 shows a promising role in DNA repair, leucocyte adhesion, and smooth muscle proliferation. These significant roles make LAM3 a promising candidate for therapeutic applications involving cancer, regenerative medicine, and inflammatory disease. LAM4 specifically shows interaction with proteins that are involved in response to hypoxia and negative regulation of proliferation suggesting their potential role in cancer treatment. These network pharmacology-based investigations revealed larixinic acid and its metabolites as promising candidates for therapeutic development.

Journal of King Saud University - ScienceVol. 0
Majmaah University (SA)
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon